cGxP.wire https://validator.w3.org/feed/docs/rss2.html Galvanize Therapeutics Reports New Immune Activity Data Henlius Reports 2026 Interim Results, Global Growth Advances Evolved By Nature Peptide Platform Advances Atopic Dermatitis Care Maverix Medical Advances Lung Cancer Diagnosis With Narwhal ASHP and APhA Call for Stronger Medication Safety Allies of Skin Launches Peptint Tripeptide Lip Treatment AbbVie Highlights Lung Cancer Pipeline Data at WCLC 2026 Revance Wins FDA Approval for RHA Redensity Eye Filler Milestone Starts Phase 3 Trial for AFib-RVR Therapy Akeso Advances AK157D1 B7-H3 ADC Into Phase I Implantica Wins FDA Approval for RefluxStop® in U.S. C2N PrecivityAD2 FDA Clearance Advances Alzheimer’s Testing Dizal to Present ZEGFROVY NSCLC Data at WCLC 2026 Leads Biolabs Advances Opamtistomig Toward Approval Chai Discovery and BMS Advance AI Antibody Discovery Vascarta Begins Phase I Study of VAS-101 in SCD Keenova Begins Phase 3 XIAFLEX Trial for Hammer Toe Alzamend Neuro Shares Lithium Imaging Data at Neuroscience 2026 IceCure Advances Breast Cancer Cryoablation Study PharmAla Advances MDXX Manufacturing and Drug Pipeline Orum Therapeutics Gains FDA Clearance for ORM-1153 Protagenic Advances PT00114 Toward FDA IND Submission Raintree Expands Agentic AI for Rehab Therapy FibroBiologics Gains Australian Patent for Disc Therapy Werewolf Therapeutics and Ambros Announce $150M Merger Alvotech Expands Biosimilar Reach With Lotus Partnership SK pharmteco Showcases Global CDMO Manufacturing at CPHI Johnson & Johnson Expands TECVAYLI for Multiple Myeloma Care RenovoRx Expands RenovoCath Patent Protection for Cancer Ipsen Completes Kartos Acquisition to Expand Oncology Pipeline Telix Strengthens Radiopharmaceutical Pipeline with Multiple Late-Stage Clinical Milestones Hyperfine Gains FDA Clearance for Next Optive AI Software Superbrewed Food Launches Shelf-Stable Thryvia Postbiotic Charles River and Medigen Advance Vaccine Development With NGS Turn Therapeutics Reports GX-03 Skin Inflammation Research Allure Beauty Concepts Expands OTC Manufacturing iECURE to Present ECUR-506 Clinical Data in OTC Deficiency Zeon Lifesciences Advances U.S. Nutraceutical Readiness VarmX Starts Phase 3 Trial of VMX-C001 in Urgent Surgery Subtle Medical Expands AI Imaging Leadership With Tanenbaum Rein Therapeutics Gains FDA Fast Track for LTI-03 in IPF Nuvation Bio Gains FDA Fast Track for Safusidenib Akiram Therapeutics and ITM Sign Lutetium-177 Supply Agreement to Advance AKIR001 in Solid Tumors FDA Authorizes Aletta Robotic Blood Draw Device Ultragenyx Wins FDA Approval for GENGLYCOS Gene Therapy Ionis and AstraZeneca Showcase Cardiovascular Pipeline Progress with New Data at ESC Congress 2026 Tolerance Bio Licenses Long-Acting IL-7 Therapy Lupin Expands Europe Access to YUVEZZI Presbyopia Therapy UroGen Expands Oncology Pipeline Through IntraGel Deal HealthTab and Abbott Expand UK Point-of-Care Testing